BioLife Solutions

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BLFS and other ETFs, options, and stocks.

About BLFS

BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. 

CEO
Roderick de Greef
CEORoderick de Greef
Employees
159
Employees159
Headquarters
Bothell, Washington
HeadquartersBothell, Washington
Founded
1987
Founded1987
Employees
159
Employees159

BLFS Key Statistics

Market cap
1.18B
Market cap1.18B
Price-Earnings ratio
-355.02
Price-Earnings ratio-355.02
Dividend yield
Dividend yield
Average volume
270.87K
Average volume270.87K
High today
$25.05
High today$25.05
Low today
$24.33
Low today$24.33
Open price
$24.88
Open price$24.88
Volume
261.11K
Volume261.11K
52 Week high
$29.62
52 Week high$29.62
52 Week low
$19.10
52 Week low$19.10

Stock Snapshot

The current BioLife Solutions(BLFS) stock price is $24.39, with a market capitalization of 1.18B. The stock trades at a price-to-earnings (P/E) ratio of -355.02.

On 2025-12-15, BioLife Solutions(BLFS) stock traded between a low of $24.33 and a high of $25.05. Shares are currently priced at $24.39, which is +0.2% above the low and -2.6% below the high.

The BioLife Solutions(BLFS)'s current trading volume is 261.11K, compared to an average daily volume of 270.87K.

In the last year, BioLife Solutions(BLFS) shares hit a 52-week high of $29.62 and a 52-week low of $19.10.

In the last year, BioLife Solutions(BLFS) shares hit a 52-week high of $29.62 and a 52-week low of $19.10.

BLFS News

Simply Wall St 6d
Will CFO Troy Wichterman’s Share Sale Amid Stronger Cell Processing Shift BioLife Solutions' Narrative

On 4 December 2025, BioLife Solutions’ CFO and 10% owner Troy Wichterman sold 30,000 shares at an average US$25.72, raising about US$771,600 and leaving him wit...

Will CFO Troy Wichterman’s Share Sale Amid Stronger Cell Processing Shift BioLife Solutions' Narrative

Analyst ratings

100%

of 10 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own BLFS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.